LAVA Therapeutics NV is a pioneering biotechnology company dedicated to transforming cancer treatment through its innovative gamma-delta bispecific T-cell activators (gamma-delta bsTCE). Based in Utrecht, the Netherlands, LAVA boasts a promising development pipeline that utilizes its proprietary technology to create next-generation therapies aimed at effectively targeting solid tumors and hematologic malignancies. With a strong commitment to enhancing immune responses against cancer, LAVA Therapeutics is poised to make significant contributions to oncology and improve patient outcomes in an increasingly competitive market.
Click "Analyze" to generate stock analysis
LVTX Price Trend and Signals
LVTX Option Volumes & Open Interests (aggregated)
LVTX Put Call Ratios and IV (aggregated)
LVTX Financials
2025-10-23Bullishmacd_signal
Golden cross below zero detected.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.